UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009871
Receipt No. R000011567
Scientific Title Phase II study of continuation maintenance by use of TS1 and Bevacizumab after induction chemotherapy of cisplatin and TS1 pulse bevacizumab in patients with Stage IIIB / IV non-squamous and non-small cell lung cancer - Research of efficacy predictive biomarker
Date of disclosure of the study information 2013/01/31
Last modified on 2018/09/29 16:31:49

No. Disposal Last modified on Item of update
1 Insert 2013/01/25 17:10:08
2 Update 2013/08/25 10:59:14 Email
3 Update 2014/01/25 09:41:52 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
4 Update 2016/09/02 16:12:00 Name of primary sponsor
Organization
5 Update 2018/05/11 15:10:54 Recruitment status
Last follow-up date
6 Update 2018/09/29 16:30:58 Recruitment status
Last follow-up date
7 Update 2018/09/29 16:31:49 Name of primary sponsor
Co-sponsor
Co-sponsor


Contact us.